Pancreatic fistula ERCP: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Endoscopic retrograde cholangiopancreatography (ERCP) is used to diagnose as well as treat the fistula with placement of pancreatic stent during the procedure. ERCP demonstrate filling of the pancreatic duct with contrast and extravasation of the contrast suggesting disruption of the pancreatic duct. | [[Endoscopic retrograde cholangiopancreatography]] (ERCP) is used to diagnose as well as treat the [[fistula]] with placement of [[pancreatic]] [[stent]] during the procedure. [[ERCP]] demonstrate filling of the [[pancreatic duct]] with [[contrast]] and extravasation of the [[contrast]] suggesting disruption of the [[pancreatic duct]]. | ||
==ERCP== | ==ERCP== | ||
A pancreatic fistula can be directly visualized via [[Endoscopic retrograde cholangiopancreatography]] (ERCP). ERCP can be used for diagnosis as well as therapeutic purposes and is the test of choice for the placement of therapeutic pancreatic stent during the procedure to facilitate the closure of pancreatic fistula. ERCP has a higher sensitivity and specificity compared to other imaging modalities to detect the pancreatic duct leak. Pancreatic duct filling with contrast and extravasation of the contrast are findings suggestive of the pancreatic fistula caused by the disruption of the pancreatic duct.<ref name="pmid24650171">{{cite journal| author=Larsen M, Kozarek R| title=Management of pancreatic ductal leaks and fistulae. | journal=J Gastroenterol Hepatol | year= 2014 | volume= 29 | issue= 7 | pages= 1360-70 | pmid=24650171 | doi=10.1111/jgh.12574 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24650171 }} </ref> | A [[pancreatic]] [[fistula]] can be directly visualized via [[Endoscopic retrograde cholangiopancreatography]] ([[ERCP]]). [[ERCP]] can be used for diagnosis as well as therapeutic purposes and is the test of choice for the placement of [[therapeutic]] [[pancreatic]] [[stent]] during the procedure to facilitate the closure of [[pancreatic]] [[fistula]]. [[ERCP]] has a higher sensitivity and specificity compared to other imaging modalities to detect the [[pancreatic duct]] leak. [[Pancreatic duct]] filling with [[contrast]] and extravasation of the [[contrast]] are findings suggestive of the [[pancreatic]] [[fistula]] caused by the disruption of the [[pancreatic duct]].<ref name="pmid24650171">{{cite journal| author=Larsen M, Kozarek R| title=Management of pancreatic ductal leaks and fistulae. | journal=J Gastroenterol Hepatol | year= 2014 | volume= 29 | issue= 7 | pages= 1360-70 | pmid=24650171 | doi=10.1111/jgh.12574 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24650171 }} </ref> | ||
==References== | ==References== | ||
Latest revision as of 19:51, 4 April 2021
|
Pancreatic fistula Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pancreatic fistula ERCP On the Web |
|
American Roentgen Ray Society Images of Pancreatic fistula ERCP |
|
Risk calculators and risk factors for Pancreatic fistula ERCP |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Endoscopic retrograde cholangiopancreatography (ERCP) is used to diagnose as well as treat the fistula with placement of pancreatic stent during the procedure. ERCP demonstrate filling of the pancreatic duct with contrast and extravasation of the contrast suggesting disruption of the pancreatic duct.
ERCP
A pancreatic fistula can be directly visualized via Endoscopic retrograde cholangiopancreatography (ERCP). ERCP can be used for diagnosis as well as therapeutic purposes and is the test of choice for the placement of therapeutic pancreatic stent during the procedure to facilitate the closure of pancreatic fistula. ERCP has a higher sensitivity and specificity compared to other imaging modalities to detect the pancreatic duct leak. Pancreatic duct filling with contrast and extravasation of the contrast are findings suggestive of the pancreatic fistula caused by the disruption of the pancreatic duct.[1]
References
- ↑ Larsen M, Kozarek R (2014). "Management of pancreatic ductal leaks and fistulae". J Gastroenterol Hepatol. 29 (7): 1360–70. doi:10.1111/jgh.12574. PMID 24650171.